AKT1 and thyroid cancer: In an in vitro model of thyroid cancer, oncogenic RET/PTC, present only in PTC, induces ß-catenin stabilization and nuclear accumulation by a Wnt-independent mechanism involving activation of PI3K/AKT and MAPK signaling pathways [25–27].